| Filed On | Filing |
|---|---|
| 18 Sep 2026 |
Form 4/A: Lennon David James, Director
Granted 193,957 Stock option (right to buy) · Granted 193,957 Restricted Stock Units |
| 18 Sep 2026 |
Form 4/A: Dugan Margaret, Chief Medical Officer
Granted 81,250 Stock Option (right to buy) · Granted 81,250 Restricted Stock Units |
| 18 Sep 2026 |
Form 4/A: Dornan David, Chief Scientific Officer
Granted 85,887 Stock Option (right to buy) · Granted 85,887 Restricted Stock Units |
| 18 Sep 2026 |
Form 4/A: Ball Bryan, See remarks
Granted 91,633 Stock Option (right to buy) · Granted 91,633 Restricted Stock Units |
| 18 Sep 2026 |
Form 4/A: Giacobello Scott M., CHIEF FINANCIAL OFFICER
Granted 118,476 Stock Option (right to buy) · Granted 118,476 Restricted Stock Units |
| 31 Aug 2021 |
Form 4/A: Dalal Anupam, Director
Bought 1,529,402 shares ($20M) |
Loading...